Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis

被引:23
|
作者
Botzoris, Vasileios [1 ]
Drosos, Alexandros A. [1 ]
机构
[1] Univ Ioannina, Sch Med, Rheumatol Clin, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
Raynaud's phenomenon; Digital ulcers; Systemic sclerosis; Vasculopathy; Management; CALCIUM-CHANNEL BLOCKERS; RECEPTOR ANTAGONIST BOSENTAN; DOUBLE-BLIND; PHENOMENON SECONDARY; GLYCERYL TRINITRATE; SINGLE-CENTER; SCLERODERMA; THERAPY; INHIBITOR; MULTICENTER;
D O I
10.1016/j.jbspin.2010.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Raynaud's phenomenon (RP) and digital ulcers (DU) are the clinical manifestations of vasculopathy in systemic sclerosis. Both interfere with hand function and hold the possibility of severe complications, thus adversely influencing patients' quality of life. Managing RP and DU is often a challenge for the treating physician, who has to establish a treatment plan based upon knowledge of the current therapeutic options. The first step is to differentiate primary from secondary RP, where combining history and physical examination with diagnostic modalities, such as nailfold capillaroscopy, aids in reaching the correct diagnosis. Next a wide range of treatment options is offered nowadays, starting from first-line agents, as calcium channel blockers, to the more targeted-ones, like endothelin receptor antagonists. Research and clinical experience with each agent are reviewed in the text, as well as the combinations that more recently gain field in the treatment of DU. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 50 条
  • [1] Raynaud phenomenon and digital ulcers in systemic sclerosis
    Hughes, Michael
    Allanore, Yannick
    Chung, Lorinda
    Pauling, John D.
    Denton, Christopher P.
    Matucci-Cerinic, Marco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (04) : 208 - 221
  • [2] Raynaud phenomenon and digital ulcers in systemic sclerosis
    Michael Hughes
    Yannick Allanore
    Lorinda Chung
    John D. Pauling
    Christopher P. Denton
    Marco Matucci-Cerinic
    [J]. Nature Reviews Rheumatology, 2020, 16 : 208 - 221
  • [3] Author Correction: Raynaud phenomenon and digital ulcers in systemic sclerosis
    Michael Hughes
    Yannick Allanore
    Lorinda Chung
    John D. Pauling
    Christopher P. Denton
    Marco Matucci-Cerinic
    [J]. Nature Reviews Rheumatology, 2021, 17 : 246 - 246
  • [4] Management of Raynaud’s Phenomenon and Digital Ulcers
    Fredrick M. Wigley
    Ariane L. Herrick
    [J]. Current Treatment Options in Rheumatology, 2015, 1 (1) : 68 - 81
  • [5] Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
    Arefiev, Kait
    Fiorentino, David F.
    Chung, Lorinda
    [J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2011, 2011
  • [6] Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
    Korsten, Peter
    Muller, Gerhard A.
    Rademacher, Jan-Gerd
    Zeisberg, Michael
    Tampe, Bjoern
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [7] Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis
    Gore, J
    Silver, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1387 - 1387
  • [8] Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases
    Santiago, T.
    Duarte, A. C.
    Sepriano, A.
    Castro, A.
    Rosa, B.
    Resende, C.
    Oliveira, D.
    Dourado, E.
    Costa, E.
    Cunha-Santos, F.
    Terroso, G.
    Boleto, G.
    Silva, I.
    Barbosa, L.
    Silva, J.
    Neves, J. Sousa
    Salvador, M. J.
    Goncalves, M. J.
    Guerra, M. Gomes
    Ferreira, R. M.
    Duarte-Fernandes, R.
    Barreira, S.
    Teixeira, V. Silvestre
    Tomas, A. L.
    Ramao, V. C.
    Cordeiro, A.
    [J]. ARP RHEUMATOLOGY, 2024, 3 (02): : 84 - 94
  • [9] Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis
    Fernandez-Codina, Andreu
    Kazem, Mikameh
    Pope, Janet E.
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 963 - 965
  • [10] Possible benefit of tadalafil cream for the treatment of Raynaud’s phenomenon and digital ulcers in systemic sclerosis
    Andreu Fernández-Codina
    Mikameh Kazem
    Janet E. Pope
    [J]. Clinical Rheumatology, 2020, 39 : 963 - 965